📰 Cosmetics Rules News
Cosmetics Rules News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cosmetics Rules. Real-time updates on events, politics, business and more.
May 31, 2024
The Supreme Court on Tuesday grilled the Central government on why it asked AYUSH authorities in states and union territories not to take any action against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945 (Indian Medical Association & Anr v. Union of India and Ors).
May 31, 2024
The Supreme Court on Tuesday slammed the Uttarakhand State Licensing Authority (SLA) for its failure to take inaction against Patanjali Ayurved for years together.
May 15, 2024
The court said there is no doubt that Ramdev and his team played a big role in taking yoga to the world stage, the matter concerning Patanjali products is a different thing | Latest News India
May 7, 2024
The Union government on Monday defended in the Supreme Court its August 2023 missive to states and Union territories asking authorities not to initiate action against any entity for violating Rule 170 of the Drugs & Cosmetics Rules | Latest News India
May 7, 2024
The Court noted that a letter issued by the Centre in 2023 effectively put on hold the implementation of Rule 170, which requires licensing authorities to sign off on AYUSH ads.
May 7, 2024
The Central government has defended before the Supreme Court its letter asking State/UT licensing authorities to not take action against ads pertaining to Ayurvedic and Ayush products under Rule 170...
May 3, 2024
Specific regulations for the medical device industry will streamline the approval process, enabling manufacturers to secure clinical trial approvals and sales licences in a short period
May 3, 2024
KV Babu’s initiatives have had a lasting impact on the fight against misleading medical claims, especially claims about curing serious diseases. | Latest News India
May 2, 2024
A government-appointed panel is considering allowing commonly used cough and cold medicines, antacids, and fever-reducing drugs to be sold over the counter (OTC) at general stores in India. While countries like Britain, the US, and Australia have clear guidelines for OTC drug sale, India lacks such regulations. In 2022, India approved a new OTC drug policy, but it was not implemented.
May 1, 2024
Patanjali: During the hearing on Tuesday, a bench of Justices Hima Kohli and Ahsanuddin Amanullah came down heavily on the SLA for its "inaction" for six years in the matter, saying it has to be honest with the court if it wanted "sympathy and compassion".